StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Ajit Mishra, Religare

BUYSun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries share price target & all analyst calls

byAjit Mishra, ReligareHorizon: NA (inferred Swing (≤2wk))9 Jul 2026via Business Standard Markets

Entry₹1,888.2Stated
Target₹2,025
Total upside +7.24% (call closed)
Stop loss₹1,830-3.08% risk
At expiry₹1,943.922 Jul 2026, 3:30 pm
Expired+2.95%
Follow Ajit Mishra for new calls(22% target hit, 114 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 22 Jul 2026
2 supporting0 opposing
Supports the BUY call (2)

Sun Pharmaceutical Industries Limited has received approval to manufacture and market a generic version of semaglutide in South Africa, expanding its product portfolio and market access.

NSE · Press Release·15 Jul · 1w ago

(opens in new tab)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·15 Jul · 1w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Sun Pharmaceutical Industries

All analyst calls on Sun Pharmaceutical Industries

More from Ajit Mishra, Religare

Every call and its outcome